Inso Biosciences

Inso Biosciences is a private, pre-revenue biotech startup spun out of Cornell University, founded in 2019 and based in Ithaca, New York. The company has developed a patented microfluidic platform that physically entraps DNA on micropillars, enabling rapid, automated extraction of ultra-long DNA fragments with minimal degradation. This technology addresses key bottlenecks in next-generation sequencing sample prep, promising superior DNA quality, faster turnaround, and built-in capabilities for multi-omics and host depletion. With a seasoned leadership team and prestigious advisors, Inso Bio is positioning itself to democratize advanced genomic analysis.

Microfluidic system using micropillars for physical capture and purification of high molecular weight DNA and RNA, enabling rapid, automated sample preparation for sequencing.

Inso Bio competes with large, established players like Qiagen, Thermo Fisher, and PacBio who offer bead- and column-based extraction kits, as well as other startups in the microfluidics and automation space. Its differentiation is the physical capture method for superior HMW DNA recovery, but it must overcome high switching costs and prove a compelling value proposition.